Investment Summary |
|
|---|---|
| Date | 2022-01-27 |
| Target | Nobi |
| Sector | Medical Products |
| Investor(s) | EQT Life Sciences |
| Deal Type | Growth Capital |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1987 |
| PE ASSETS | 3.5B EUR |
| Size | Large |
| Type | Sector Focused |
EQT Life Sciences (formerly Life Science Partners) is a private investment firm focused on growth and venture capital financing for life sciences and healthcare companies. The Firm targets early to mid?stage companies in sectors such as therapeutics, medical devices, diagnostics, healthtech, and biotech. EQT Life Sciences was formed in 1986 and is headquartered in Amsterdam, the Netherlands.
| DEAL STATS | # |
|---|---|
| Overall | 45 of 47 |
| Sector: Medical Products M&A | 14 of 14 |
| Type: Growth Capital M&A Deals | 4 of 5 |
| Country: Belgium M&A | 5 of 5 |
| Year: 2022 M&A | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-12-08 |
AviadoBio
London, United Kingdom AviadoBio is a pioneering gene therapy company focused on developing and delivering transformative medicines for people living with neurodegenerative disorders. AviadoBio was founded in 2019 and is based in London, United Kingdom, |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-02-09 |
Perfuze
Galway, Ireland Perfuze is a medical device company developing next-generation catheter-based aspiration technology to treat large vessel occlusion acute ischemic stroke. Perfuze was founded in 2018 and is based in Galway, Ireland. |
Buy | - |
